While generally safe, certain individuals should avoid AOD-9604, including: Pregnant or breastfeeding women Due to limited safety data
Now the program offers three pathways for some Medicare subscribers to qualify for coverage. To view or add a comment, sign in Millions Of Older Americans Now Qualify For GLP-1s Under New Medicare Program Reuters (7/1, Prentice, Niasse) reports a Medicare program starting on Wednesday allows millions of people to qualify for GLP-1 medications for just $50 a month, bringing the highly effective drugs to people aged 65 and older at an affordable price. The 18-month CMS trial program will offer for the first time Novo Nordisks Wegovy and Eli Lillys Foundayo and Zepbound as a weight-loss treatment alone. In the past, Medicare was barred from weight-loss coverage and had paid for the drugs only when prescribed for co-conditions like cardiovascular issues and severe fatty liver disease
Regular physical activity, stress management, and sleep optimization all support weight stability and improve fertility outcomes
A named provider: there should be a licensed clinician responsible for your care who you can reach with questions or side effects
Fatigue and stress can exacerbate nausea, so prioritizing good sleep and practicing stress-reduction techniquessuch as deep breathing, meditation, or gentle exercisecan make a difference
